Literature DB >> 7270084

Olivary enlargement: chronological and morphometric analyses.

N Goto, M Kaneko.   

Abstract

Chronologic and morphometric changes in the inferior olivary nucleus of the human medulla oblongata were studied in eight cases of primary pontine hemorrhage with different survival periods. To measure the olivary areas and analyze the neuronal and glial components, an optic electronic planimeter was used. A desk-top computer was also used for the calculation of the obtained data. The olivary enlargement was observed in cases with survival periods ranging from 3 weeks after the onset to 9.5 months. A morphometric analysis revealed six different stages of olivary changes after the destruction of the central tegmental tract in the pons: (1) no olivary changes, (2) olivary amiculum degeneration, (3) olivary hypertrophy, (4) culminant olivary enlargement, (5) olivary pseudohypertrophy, and (6) olivary atrophy. In stage (3) - noticed here for the first time -, neuronal cellular hypertrophy and sclerotic neurons with "insect-bite appearance" were observed. In stages (4) and (5), we also found the presence of prominent gemistocytic astrocytes in the characteristically enlarged inferior olivary nuclei. However, no proliferation of astrocytes during the olivary enlargement was confirmed in the morphometric analysis.

Entities:  

Mesh:

Year:  1981        PMID: 7270084     DOI: 10.1007/BF00697000

Source DB:  PubMed          Journal:  Acta Neuropathol        ISSN: 0001-6322            Impact factor:   17.088


  13 in total

1.  Hypertrophy of the inferior olives. Report on 29 cases.

Authors:  K Jellinger
Journal:  Z Neurol       Date:  1973

2.  Neurofilamentous hyperplasia in inferior olivary hypertrophy.

Authors:  D S Horoupian; H Wiśniewski
Journal:  J Neuropathol Exp Neurol       Date:  1971-10       Impact factor: 3.685

3.  [Somatotopic relation of segmentary degenerations of the superior cerebellar peduncle secondary to limited lesions of the homolateral nucleus dentatus in man].

Authors:  M Ben Hamida; J Lapresle
Journal:  Rev Neurol (Paris)       Date:  1969-04       Impact factor: 2.607

4.  [Wernekink's commissure syndrome caused by a vascular malformation. Associated olivary and cerebellar degeneration].

Authors:  R Garcin; P Castaigne; P Rondot; R Escourolle; J L Ribadeau-Dumas
Journal:  Rev Neurol (Paris)       Date:  1971-06       Impact factor: 2.607

5.  [Two types of pseudohypertrophy of the olive with broken triangles of Guillain and Mollaret. A quantitative study with serial sections (author's transl)].

Authors:  N Goto; M Kaneko; T Koba; Y Hosaka
Journal:  Rinsho Shinkeigaku       Date:  1979-05

6.  Hypertrophic olivary degeneration and Purkinje cell degeneration in a case of long-standing head injury.

Authors:  J R Anderson; C S Treip
Journal:  J Neurol Neurosurg Psychiatry       Date:  1973-10       Impact factor: 10.154

7.  Olivary hypertrophy without palatal myoclonus associated with a metastatic lesion to the pontine tegmentum.

Authors:  J J Robin; H Alcala
Journal:  Neurology       Date:  1975-08       Impact factor: 9.910

8.  Pure motor hemiplegia, medullary pyramid lesion, and olivary hypertrophy.

Authors:  J E Leestma; A Noronha
Journal:  J Neurol Neurosurg Psychiatry       Date:  1976-09       Impact factor: 10.154

9.  Olivary hypertrophy: histochemical demonstration of hydrolytic enzymes.

Authors:  A H Koeppen; K D Barron; M P Dentinger
Journal:  Neurology       Date:  1980-05       Impact factor: 9.910

10.  Primary pontine hemorrhage: clinicopathological correlations.

Authors:  N Goto; M Kaneko; Y Hosaka; H Koga
Journal:  Stroke       Date:  1980 Jan-Feb       Impact factor: 7.914

View more
  42 in total

1.  Collision in the inferior olive: hypertrophic olivary degeneration complicated by radiation necrosis in brainstem primitive neuroendocrine tumor.

Authors:  Patricia Litkowski; Robert J Young; Suzanne L Wolden; Mark M Souweidane; Sofia Haque; Stephen W Gilheeney
Journal:  Clin Imaging       Date:  2012-06-08       Impact factor: 1.605

Review 2.  Morphometric evaluations of the human nervous system.

Authors:  Noboru Goto; Jun Goto
Journal:  Hum Cell       Date:  2006-05       Impact factor: 4.174

3.  Hypertrophic olivary degeneration with gadolinium enhancement after posterior fossa surgery in a child with medulloblastoma.

Authors:  Johannes Nowak; Balint Alkonyi; Stefan Rutkowski; György A Homola; Monika Warmuth-Metz
Journal:  Childs Nerv Syst       Date:  2014-05       Impact factor: 1.475

4.  Hypertrophic olivary degeneration following pontine cavernoma hemorrhage: a typical change accompanying lesions in the Guillain-Mollaret triangle.

Authors:  Stephan Macht; Daniel Hänggi; Bernd Turowski
Journal:  Klin Neuroradiol       Date:  2009-07-16

5.  Olivary hypertrophy precedes the appearance of palatal myoclonus.

Authors:  T Yokota; H Tsukagoshi
Journal:  J Neurol       Date:  1991-10       Impact factor: 4.849

6.  Hypertrophic olivary degeneration secondary to traumatic brain injury: a unique form of trans-synaptic degeneration.

Authors:  Raman Mehrzad; Michael G Ho
Journal:  BMJ Case Rep       Date:  2015-07-02

7.  Segmental Myorhythmia with Palatal Tremor Due to Bilateral Hypertrophic Olivary Degeneration in Wilson Disease.

Authors:  Yury Seliverstov; Aleksandr Suslin; Elena Kremneva; Marina Krotenkova
Journal:  Mov Disord Clin Pract       Date:  2020-08-05

8.  Posttraumatic bilateral hypertrophic olivary degeneration.

Authors:  Eberhard Siebert; Lutz Harms; Martin Herbst
Journal:  Neurol Sci       Date:  2013-02-01       Impact factor: 3.307

9.  Hypertrophic olivary degeneration: metaanalysis of the temporal evolution of MR findings.

Authors:  M Goyal; E Versnick; P Tuite; J S Cyr; W Kucharczyk; W Montanera; R Willinsky; D Mikulis
Journal:  AJNR Am J Neuroradiol       Date:  2000 Jun-Jul       Impact factor: 3.825

10.  Olivary degeneration after cerebellar or brain stem haemorrhage: MRI.

Authors:  A Uchino; K Hasuo; K Uchida; S Matsumoto; Y Tsukamoto; M Ohno; K Masuda
Journal:  Neuroradiology       Date:  1993       Impact factor: 2.804

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.